TG Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.

CEO

Michael Sean Weiss

CEOMichael Sean Weiss

Employees

338

Employees338

Headquarters

Morrisville, North Carolina

HeadquartersMorrisville, North Carolina

Founded

1993

Founded1993

Employees

338

Employees338

TGTX Key Statistics

Market cap

6.20B

Market cap6.20B

Price-Earnings ratio

270.85

Price-Earnings ratio270.85

Dividend yield

—

Dividend yield—

Average volume

2.86M

Average volume2.86M

High today

—

High today—

Low today

—

Low today—

Open price

$38.75

Open price$38.75

Volume

0.00

Volume0.00

52 Week high

$43.32

52 Week high$43.32

52 Week low

$12.93

52 Week low$12.93

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

Sell

14.3%